Chimeric Antigen Receptor-Engineered T Cells for the Treatment of Metastatic Prostate Cancer
Crossref DOI link: https://doi.org/10.1007/s40259-015-0122-9
Published Online: 2015-04-10
Published Print: 2015-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hillerdal, Victoria
Essand, Magnus
License valid from 2015-04-01